--- title: "Xintian Pharma's controlling shareholder, Xintian Zhiyao, plans to reduce its holdings by no more than 7.05 million shares" type: "News" locale: "en" url: "https://longbridge.com/en/news/261908881.md" description: "According to the Zhitong Finance APP, Xintian Pharma announced that its controlling shareholder Shanghai Xintian Zhiyao Biotechnology Co., Ltd. (referred to as \"Xintian Zhiyao\") plans to reduce its holdings of the company's shares by no more than 7.05 million shares through block trades and centralized bidding from November 11, 2025, to February 10, 2026, accounting for 2.9962% of the total share capital after excluding shares in the company's repurchase special account" datetime: "2025-10-20T14:02:04.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/261908881.md) - [en](https://longbridge.com/en/news/261908881.md) - [zh-HK](https://longbridge.com/zh-HK/news/261908881.md) --- # Xintian Pharma's controlling shareholder, Xintian Zhiyao, plans to reduce its holdings by no more than 7.05 million shares According to the Zhitong Finance APP, Xintian Pharma (002873.SZ) announced that its controlling shareholder Shanghai Xintian Zhiyao Biotechnology Co., Ltd. (referred to as "Xintian Zhiyao") plans to reduce its holdings of the company's shares by no more than 7.05 million shares through block trading and centralized bidding from November 11, 2025, to February 10, 2026, accounting for 2.9962% of the total share capital after excluding the shares in the company's repurchase special account ### Related Stocks - [002873.CN](https://longbridge.com/en/quote/002873.CN.md) ## Related News & Research - [UTG Chairman and CEO Jesse T. Correll buys 4,850 shares for $266,556.00](https://longbridge.com/en/news/287109106.md) - [16:51 ETBeverly Hills MD ProRetinol Age Rewind x3 Officially Launches: A New Era of Gentle, Slow-Released Retinol Skincare Backed by Plastic Surgeons](https://longbridge.com/en/news/286966075.md) - [Orkla’s OV UK Buys Phoenix Brands to Boost Sweet Ingredients Footprint](https://longbridge.com/en/news/286763926.md) - [AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain](https://longbridge.com/en/news/286879044.md) - [](https://longbridge.com/en/news/286948461.md)